Table 1

Clinical baseline characteristics of study patients

CharacteristicPatients (n=24)
Gender, n (%)
 Male10 (41.7)
 Female14 (58.3)
Age (year)
 Mean±SD60.13±9.37
 Range45–84
Weight (kg)
 Mean±SD65.61±12.48
 Range48.5–105
 Smoke history (yes, %)11 (45.8)
 Pleural effusion (yes, %)15 (62.5)
Tumor burden (cm)
 Mean±SD4.55±2.38
 Range1.0–10.4
 Tumor number (S–M)5–19
 EGFR mutation (yes,%)16 (66.7)
Clinical stage
 IIIA/B5
 IV19
Previous treatment strategies:
 Surgery (yes, %)4 (16.7)
 Radiotherapy (yes, %)18 (75.0)
 Chemotherapy (yes, %)17 (70.8)
 EGFR inhibitor (yes, %)16 (66.7)
 Brian metastases (yes,%)1 (4.2)
 Tumor histology (SQ-AD)6–18
  • AD, adenocarcinoma; EGFR, epidermal growth factor receptor; M, multiple; S, single; SQ, squamous cell carcinoma.